简体中文 | 繁體中文 | English

Cegedim Dendrite

Cegedim Dendrite Announces Broad Expansion of Alliance Program

2009-03-05 14:24
  • zh_cn
  • zh_hant
  • en

Customers to Benefit from an Open Business Model

BARCELONA, Spain--(BUSINESS WIRE)--Cegedim Dendrite today announced the expansion of its Alliance Program at the eyeforpharma Sales Force Effectiveness (SFE) Europe 2009 Conference. Embracing an Open Business Model, Cegedim Dendrite is expanding formal partnerships with selected technology, software and consulting companies in order to provide additional capabilities and services to customers. Cegedim Dendrite is the leading provider of Customer Relationship Management (CRM) solutions to the pharmaceutical industry.

Pharmaceutical and life science companies are looking for solutions that will facilitate incremental growth, increased productivity and effectiveness. Cegedim Dendrite meets this need by providing tools that are optimally adapted to address the complex problems of the medical information business. With the Open Model, industry leading solutions are now enhanced by strategic alliances which will ensure the availability of complementary products and services aimed at delivering total customer satisfaction.

“An Open Business Model – particularly partnerships with other industry leaders – fosters innovation and improved customer satisfaction,” stated Laurent Labrune, Chief Executive Officer at Cegedim Dendrite. “We will be building strong partnerships with other best-of-breed companies that have offerings that complement our products and services, in order to give our customers a technological edge in a very competitive market.”

The Alliance Program will accommodate three different types of businesses. Technology Partners are companies that offer technology and platform solutions that support and enhance the performance of Cegedim Dendrite business applications. Software Partners are companies with software products that complement Cegedim Dendrite’s applications. Consulting Partners provide a range of services associated with the optimal use of Cegedim Dendrite products and services.

“We are very excited about partnering with Cegedim Dendrite due to their leadership and innovation as a partner to the pharmaceutical and life science industry,” said Pierre Germain, Associate Director, Life Sciences for Capgemini. “We are confident that break-through solutions will be delivered to the market through the collaboration of the two companies. The combination of Capgemini service offerings and Cegedim Dendrite software and services will be a unique value in the market.”

Cegedim Dendrite is being very selective, and partnering only with category leaders who are similarly committed to total customer satisfaction and success.

About Cegedim Dendrite

Cegedim Dendrite provides pharmaceutical companies around the world with vital support for successful Customer Relationship Management (CRM) activities. With nearly 200,000 sales representatives using its products worldwide, Cegedim Dendrite is the world’s leading CRM provider for the life sciences industry. This business unit, created in May 2007 when the France-based CEGEDIM S.A. Group acquired Dendrite International, Inc., provides sales, marketing and regulatory compliance solutions in more than 80 countries. To learn more, please visit www.cegedimdendrite.com/.

About CEGEDIM

Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, pharmaceutical companies, healthcare professionals and insurance companies. The world leader in pharmaceutical CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs nearly 8,000 people in 80 countries and generated revenue of €849 million in 2008. To learn more, please visit www.cegedim.com.

Cegedim is listed on NYSE Euronext Paris, compartment B – ISIN FR0000053506 – Reuters CGDM.PA – Bloomberg CGM.

Contacts

Cegedim Dendrite

U.S.

Global Communications

Drew Bustos, 908-443-2451

drew.bustos@cegedimdendrite.com

or

CEGEDIM

Media Relations

Aude Balleydier, + 33 (0) 1 49 09 67 73

aude.balleydier@cegedim.fr